BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
43 results:

  • 1. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
    Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
    Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.
    Masuda T; Kosaka T; Nakamura K; Hongo H; Yuge K; Nishihara H; Oya M
    BMC Med Genomics; 2022 May; 15(1):118. PubMed ID: 35598018
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
    Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
    JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Methylation detection of phosphatase and tensin homolog deleted on chromosome ten gene promoter in hepatocellular carcinoma samples by next-generation sequencing].
    Jing XK; Jiang QY; Li CS; Zhang NR; Chai YT; Feng F; Li BA; Li YK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Oct; 55(10):1220-1227. PubMed ID: 34706508
    [No Abstract]    [Full Text] [Related]  

  • 8. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.
    Li P; Song R; Yin F; Liu M; Liu H; Ma S; Jia X; Lu X; Zhong Y; Yu L; Li X; Li X
    Mol Ther; 2022 Jan; 30(1):431-447. PubMed ID: 34450251
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
    Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression.
    Cao Z; Cheng Y; Wang J; Liu Y; Yang R; Jiang W; Li H; Zhang X
    J Exp Clin Cancer Res; 2021 Apr; 40(1):118. PubMed ID: 33794968
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/pten pathway.
    Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Chen C; Chen L; Lin S; Luo X; Zheng J
    Cell Death Dis; 2021 Feb; 12(2):162. PubMed ID: 33558466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Precise therapeutic effect of self-assembling gold nanocluster-pten complexes on an orthotropic model of liver cancer.
    Wang M; Wang L; Feng H; Jiang H; Zhou J; Wang X
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):875-882. PubMed ID: 32107624
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Mutational Features of Aristolochic Acid-Induced Mouse and Human liver cancers.
    Lu ZN; Luo Q; Zhao LN; Shi Y; Wang N; Wang L; Han ZG
    Hepatology; 2020 Mar; 71(3):929-942. PubMed ID: 31692012
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Downregulated miR-328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting pten.
    Liang F; Cui ZJ; Liu JD; Liu KP; Li L; Chen YL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6324-6332. PubMed ID: 30338800
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High-expressed CKS2 is associated with hepatocellular carcinoma cell proliferation through down-regulating pten.
    Ji X; Xue Y; Wu Y; Feng F; Gao X
    Pathol Res Pract; 2018 Mar; 214(3):436-441. PubMed ID: 29487004
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pten: A potential prognostic marker in virus-induced hepatocellular carcinoma.
    Khalid A; Hussain T; Manzoor S; Saalim M; Khaliq S
    Tumour Biol; 2017 Jun; 39(6):1010428317705754. PubMed ID: 28621226
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.